Fresenius Medical price target raised to EUR 37.30 from EUR 35.40 at JPMorgan

JPMorgan raised the firm’s price target on Fresenius Medical (FMS) to EUR 37.30 from EUR 35.40 and keeps an Underweight rating on the shares.